Ranevetmab

Names

[ Name ]:
Ranevetmab

Biological Activity

[Description]:

Ranevetmab (NV-01) is a caninised anti-NGF monoclonal antibody (mAb). Ranevetmab can alleviate pain, and is used for the research of degenerative joint disease (DJD) pain[1].

[Related Catalog]:

Research Areas >> Inflammation/Immunology

[Target]

NGF

[In Vivo]

Ranevetmab (200 μg/kg，静脉注射) 减轻狗的退行性关节病 (DJD) 疼痛[1]。 Animal Model: Dogs with degenerative joint disease (DJD) pain[2] Dosage: 200 μg/kg Administration: i.v. Result: Improved canine brief pain inventory (CBPI), pain severity (PS) and pain interference (PI) scores.

[References]

[1]. Lascelles BD, et al. A canine-specific anti-nerve growth factor antibody alleviates pain and improves mobility and function in dogs with degenerative joint disease-associated pain. BMC Vet Res. 2015 Apr 30;11:101.

Chemical & Physical Properties

No Any Chemical & Physical Properties

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.